OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $226,552 | +13.3% | 42,989 | -10.8% | 0.00% | 0.0% |
Q3 2022 | $200,000 | +25.0% | 48,210 | +20.8% | 0.00% | 0.0% |
Q2 2022 | $160,000 | -3.0% | 39,896 | +20.0% | 0.00% | 0.0% |
Q1 2022 | $165,000 | -87.1% | 33,240 | -81.9% | 0.00% | -91.7% |
Q4 2021 | $1,277,000 | +39.7% | 183,234 | +100.5% | 0.01% | 0.0% |
Q3 2021 | $914,000 | +165.7% | 91,369 | +276.8% | 0.01% | +200.0% |
Q2 2021 | $344,000 | -5.0% | 24,246 | +38.7% | 0.00% | -20.0% |
Q4 2020 | $362,000 | +65.3% | 17,487 | -39.4% | 0.01% | +66.7% |
Q3 2020 | $219,000 | +40.4% | 28,838 | +54.1% | 0.00% | 0.0% |
Q2 2020 | $156,000 | – | 18,718 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |